Ambroxol, a cough medication, may help stabilize the neuropsychiatric symptoms of Parkinson's disease dementia, a new study ...

Patients with neuro conditions are asked to consult with their neurologist, above all else, before seeking out therapeutic solutions not previously approved by the FDA, according to a position paper ...

Ambroxol, long used for coughs in Europe, stabilized symptoms and brain-damage markers in Parkinson’s dementia patients over ...

Bassett Healthcare Network has added four healthcare practitioners to its team, expanding care in internal medicine, family ...

Intravenous thrombolysis remains a standard treatment for acute ischemic stroke within 4.5 hours after onset. Vascular ...

Dystonia involves involuntary muscle contractions, but you're not out of options. Discover how botulinum toxin, DBS, and ...

Dr L’Erario discusses neurologic care for TGD patients, highlighting key challenges, best practices, & steps toward more ...

Illinois engineers fused ultrafast imaging with smart algorithms to peek at living brain chemistry, turning routine MRIs into ...

The American Academy of Neurology issues new guidelines to help clinicians navigate the use of unproven neurologic therapies lacking FDA approval or strong evidence.

You will evaluate patients from infancy to age 18 during this second-year rotation, contributing to decisions on pharmacological management of neurological conditions. Under faculty supervision you ...

A total of 2010 patients underwent randomization; 1010 were assigned to ANH and 1000 to usual care. Among patients with available data, 274 of 1005 (27.3%) in the ANH group and 291 of 997 (29.2% ...

Federal research funding cuts pose an “existential threat” to academic medicine that will have repercussions for patient care in the US, according to a new report from the Association of ...